
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $6.2M | $7.6M | $23.1M | |
Revenue Growth (YoY) | -- | -- | -- | 23.25% | 201.86% | |
Cost of Revenues | $3.4M | $2M | $23.2M | $63.1M | $25.1M | |
Gross Profit | -$3.4M | -$2M | -$17M | -$55.4M | -$2M | |
Gross Profit Margin | -- | -- | -274.7% | -724.97% | -8.86% | |
R&D Expenses | $14.4M | $37.9M | $58.1M | $88.4M | $124.5M | |
Selling, General & Admin | $5.7M | $29.7M | $52M | $79M | $74.3M | |
Other Inc / (Exp) | -$16M | -$56.2M | $70.2M | -$1.6M | -$28.6M | |
Operating Expenses | $20.2M | $67.6M | $110M | $167.4M | $198.8M | |
Operating Income | -$23.5M | -$69.5M | -$127.1M | -$222.8M | -$200.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$39.7M | -$125.9M | -$51.6M | -$214.8M | -$223.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -$633K | -$1.4M | |
Net Income to Company | -$39.7M | -$125.9M | -$51.6M | -$214.1M | -$222.5M | |
Minority Interest in Earnings | -- | -- | -- | $61K | $293K | |
Net Income to Common Excl Extra Items | -$39.7M | -$125.9M | -$51.6M | -$214.1M | -$222.2M | |
Basic EPS (Cont. Ops) | -$0.27 | -$1.07 | -$0.34 | -$1.35 | -$1.27 | |
Diluted EPS (Cont. Ops) | -$0.27 | -$1.07 | -$0.82 | -$1.38 | -$1.27 | |
Weighted Average Basic Share | $145.2M | $117.2M | $152.9M | $159.1M | $175M | |
Weighted Average Diluted Share | $145.2M | $117.2M | $154.1M | $159.6M | $175M | |
EBITDA | -$39M | -$124.2M | -$43.7M | -$176.3M | -$172.2M | |
EBIT | -$39.5M | -$125.7M | -$51.6M | -$210.3M | -$217.1M | |
Revenue (Reported) | -- | -- | $6.2M | $7.6M | $23.1M | |
Operating Income (Reported) | -$23.5M | -$69.5M | -$127.1M | -$222.8M | -$200.9M | |
Operating Income (Adjusted) | -$39.5M | -$125.7M | -$51.6M | -$210.3M | -$217.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $21K | $5.3M | $5.1M | |
Revenue Growth (YoY) | -- | -- | -- | 25004.76% | -3.3% | |
Cost of Revenues | $1.6M | $515K | $12.2M | $7.1M | $4.8M | |
Gross Profit | -$1.6M | -$515K | -$12.2M | -$1.8M | $261K | |
Gross Profit Margin | -- | -- | -58223.81% | -34.14% | 5.12% | |
R&D Expenses | $5.6M | $12.7M | $23.7M | $48.8M | $25.9M | |
Selling, General & Admin | $4.2M | $11.9M | $27.3M | $19.5M | $16.9M | |
Other Inc / (Exp) | -$4.8M | $67.8M | -$12.8M | $21.6M | $18.1M | |
Operating Expenses | $9.8M | $24.6M | $51M | $68.3M | $42.8M | |
Operating Income | -$11.4M | -$25.1M | -$63.3M | -$70.1M | -$42.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$16.2M | $42.7M | -$73.6M | -$46.6M | -$23.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -$152K | -$162K | |
Net Income to Company | -$16.2M | $42.7M | -$73.6M | -$46.5M | -$23.5M | |
Minority Interest in Earnings | -- | -- | -- | $129K | $21K | |
Net Income to Common Excl Extra Items | -$16.2M | $42.7M | -$73.6M | -$46.4M | -$23.5M | |
Basic EPS (Cont. Ops) | -$0.11 | $0.28 | -$0.47 | -$0.28 | -$0.12 | |
Diluted EPS (Cont. Ops) | -$0.11 | -$0.16 | -$0.47 | -$0.28 | -$0.12 | |
Weighted Average Basic Share | $145.2M | $151.6M | $155.6M | $168.1M | $191.3M | |
Weighted Average Diluted Share | $145.2M | $153.3M | $155.6M | $168.1M | $191.3M | |
EBITDA | -$11.2M | -$24.7M | -$70M | -$20M | -$13.5M | |
EBIT | -$11.4M | -$25.1M | -$73.6M | -$45M | -$22M | |
Revenue (Reported) | -- | -- | $21K | $5.3M | $5.1M | |
Operating Income (Reported) | -$11.4M | -$25.1M | -$63.3M | -$70.1M | -$42.6M | |
Operating Income (Adjusted) | -$11.4M | -$25.1M | -$73.6M | -$45M | -$22M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $6.2M | $12.9M | $22.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $851K | $35M | $57.9M | $22.9M | |
Gross Profit | -- | -$851K | -$28.7M | -$45M | $16K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $45M | $69.1M | $113.4M | $101.6M | |
Selling, General & Admin | -- | $37.4M | $67.4M | $71.3M | $71.7M | |
Other Inc / (Exp) | -$17.2M | $16.4M | -$10.4M | $32.8M | -$32M | |
Operating Expenses | -- | $82.4M | $136.4M | $184.7M | $173.3M | |
Operating Income | -- | -$83.3M | -$165.2M | -$229.7M | -$173.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$67M | -$167.9M | -$187.8M | -$201M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -$785K | -$1.4M | |
Net Income to Company | -- | -$67M | -$167.9M | -$187M | -$199.6M | |
Minority Interest in Earnings | -- | -- | -- | $190K | $185K | |
Net Income to Common Excl Extra Items | -- | -$67M | -$167.9M | -$186.8M | -$199.4M | |
Basic EPS (Cont. Ops) | -- | -$0.50 | -$1.08 | -$1.15 | -$1.12 | |
Diluted EPS (Cont. Ops) | -- | -$1.00 | -$1.45 | -$1.34 | -$1.29 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$132.8M | -$156.8M | -$126.3M | -$165.7M | |
EBIT | -- | -$134.6M | -$167.9M | -$181.7M | -$194.1M | |
Revenue (Reported) | -- | -- | $6.2M | $12.9M | $22.9M | |
Operating Income (Reported) | -- | -$83.3M | -$165.2M | -$229.7M | -$173.3M | |
Operating Income (Adjusted) | -- | -$134.6M | -$167.9M | -$181.7M | -$194.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $21K | $5.3M | $5.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.6M | $515K | $12.2M | $7.1M | $4.8M | |
Gross Profit | -$1.6M | -$515K | -$12.2M | -$1.8M | $261K | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $5.6M | $12.7M | $23.7M | $48.8M | $25.9M | |
Selling, General & Admin | $4.2M | $11.9M | $27.3M | $19.5M | $16.9M | |
Other Inc / (Exp) | -$4.8M | $67.8M | -$12.8M | $21.6M | $18.1M | |
Operating Expenses | $9.8M | $24.6M | $51M | $68.3M | $42.8M | |
Operating Income | -$11.4M | -$25.1M | -$63.3M | -$70.1M | -$42.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$16.2M | $42.7M | -$73.6M | -$46.6M | -$23.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -$152K | -$162K | |
Net Income to Company | -$16.2M | $42.7M | -$73.6M | -$46.5M | -$23.5M | |
Minority Interest in Earnings | -- | -- | -- | $129K | $21K | |
Net Income to Common Excl Extra Items | -$16.2M | $42.7M | -$73.6M | -$46.4M | -$23.5M | |
Basic EPS (Cont. Ops) | -$0.11 | $0.28 | -$0.47 | -$0.28 | -$0.12 | |
Diluted EPS (Cont. Ops) | -$0.11 | -$0.16 | -$0.47 | -$0.28 | -$0.12 | |
Weighted Average Basic Share | $145.2M | $151.6M | $155.6M | $168.1M | $191.3M | |
Weighted Average Diluted Share | $145.2M | $153.3M | $155.6M | $168.1M | $191.3M | |
EBITDA | -$11.2M | -$24.7M | -$70M | -$20M | -$13.5M | |
EBIT | -$11.4M | -$25.1M | -$73.6M | -$45M | -$22M | |
Revenue (Reported) | -- | -- | $21K | $5.3M | $5.1M | |
Operating Income (Reported) | -$11.4M | -$25.1M | -$63.3M | -$70.1M | -$42.6M | |
Operating Income (Adjusted) | -$11.4M | -$25.1M | -$73.6M | -$45M | -$22M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $29.1M | $385.3M | $322.9M | $233.1M | $272.9M | |
Short Term Investments | -- | -- | -- | $73.7M | -- | |
Accounts Receivable, Net | -- | -- | $170K | $909K | $4.6M | |
Inventory | -- | -- | $634K | $8.7M | $7.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $946K | $8.3M | $6M | $5.2M | $9.9M | |
Total Current Assets | $33M | $398.1M | $329.6M | $323.2M | $295M | |
Property Plant And Equipment | $31.3M | $83.3M | $110M | $181.8M | $181.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $12.1M | $12.2M | |
Other Intangibles | -- | -- | -- | $42.2M | $36.4M | |
Other Long-Term Assets | $135K | $1.2M | $937K | $5.1M | $2.1M | |
Total Assets | $65M | $482.6M | $440.6M | $564.3M | $527.2M | |
Accounts Payable | $2.1M | $3.1M | $7.1M | $21.3M | $9.5M | |
Accrued Expenses | $2M | $7.1M | $4.6M | $11.1M | $16.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $108K | $707K | $716K | $2.4M | $3M | |
Total Current Liabilities | $10.9M | $20.6M | $23M | $61M | $53.7M | |
Long-Term Debt | -- | -- | -- | $169.1M | $169.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $28.7M | $156.4M | $84.2M | $303.2M | $277.8M | |
Common Stock | $10K | $15K | $15K | $17K | $19K | |
Other Common Equity Adj | -- | -- | -- | -$62K | -$143K | |
Common Equity | $36.2M | $326.1M | $356.4M | $258.1M | $246.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | $3M | $2.7M | |
Total Equity | $36.2M | $326.1M | $356.4M | $261.1M | $249.4M | |
Total Liabilities and Equity | $65M | $482.6M | $440.6M | $564.3M | $527.2M | |
Cash and Short Terms | $29.1M | $385.3M | $322.9M | $306.8M | $272.9M | |
Total Debt | -- | -- | -- | $175M | $179.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $408.2M | $293.8M | $222.2M | $189.9M | |
Short Term Investments | -- | -- | -- | $40.2M | $58.3M | |
Accounts Receivable, Net | -- | -- | $21K | $1.7M | $2.9M | |
Inventory | -- | -- | $815K | $6.5M | $10.5M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $2.8M | $5.9M | $7.2M | $7.4M | |
Total Current Assets | -- | $415.5M | $301.2M | $278M | $270.2M | |
Property Plant And Equipment | -- | $89.6M | $108.5M | $174M | $178.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $12.2M | $12.2M | |
Other Intangibles | -- | -- | -- | $40M | $35.2M | |
Other Long-Term Assets | -- | $1.1M | $881K | $4.7M | $2.8M | |
Total Assets | -- | $506.3M | $410.6M | $508.9M | $499M | |
Accounts Payable | -- | $1.5M | $4.8M | $19.3M | $20.6M | |
Accrued Expenses | -- | $4.6M | $8.7M | $11.7M | $8.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $875K | $916K | $2.9M | $5.2M | |
Total Current Liabilities | -- | $17.5M | $25.1M | $56.9M | $57.8M | |
Long-Term Debt | -- | -- | -- | $168.3M | $169.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $85.2M | $98.5M | $276.8M | $261.3M | |
Common Stock | -- | $15K | $16K | $17K | $19K | |
Other Common Equity Adj | -- | -- | -- | -$53K | -$184K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | $2.8M | $2.6M | |
Total Equity | -- | $421.1M | $312.1M | $232.1M | $237.8M | |
Total Liabilities and Equity | -- | $506.3M | $410.6M | $508.9M | $499M | |
Cash and Short Terms | -- | $408.2M | $293.8M | $262.4M | $248.2M | |
Total Debt | -- | -- | -- | $176.8M | $179.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$39.7M | -$125.9M | -$51.6M | -$214.1M | -$222.5M | |
Depreciation & Amoritzation | $579K | $1.5M | $8M | $34M | $45M | |
Stock-Based Compensation | $666K | $10.7M | $30.4M | $69.5M | $58.8M | |
Change in Accounts Receivable | -- | -- | -$170K | -$370K | -$2.5M | |
Change in Inventories | -- | -- | -$634K | $4.5M | $1.1M | |
Cash From Operations | -$20.1M | -$51.3M | -$82.7M | -$104.6M | -$108.6M | |
Capital Expenditures | -- | -- | $36.2M | $61.8M | $76.2M | |
Cash Acquisitions | -- | -- | -- | -$10M | -- | |
Cash From Investing | -$27M | -$43.6M | -$36.2M | -$143M | -$1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.6M | $15M | -- | $172.5M | $4.6M | |
Long-Term Debt Repaid | -- | -$15M | -- | -$69K | -$209K | |
Repurchase of Common Stock | -- | -$27K | -$10K | -$26K | -$4K | |
Other Financing Activities | -- | $373.7M | -$587K | -$27.1M | -$7.1M | |
Cash From Financing | $65.9M | $451.1M | $56.5M | $159.6M | $150.7M | |
Beginning Cash (CF) | $10.3M | $29.2M | $385.4M | $323M | $235.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $18.9M | $356.2M | -$62.4M | -$88M | $40.7M | |
Ending Cash (CF) | $29.2M | $385.4M | $323M | $235.1M | $274.7M | |
Levered Free Cash Flow | -$47M | -$94.9M | -$119M | -$166.4M | -$184.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$16.2M | $42.7M | -$73.6M | -$46.5M | -$23.5M | |
Depreciation & Amoritzation | $141K | $448K | $3.6M | $25M | $8.4M | |
Stock-Based Compensation | $1.6M | $5.2M | $29.2M | $12.8M | $12M | |
Change in Accounts Receivable | -- | -- | $149K | $505K | $430K | |
Change in Inventories | -- | -- | -$181K | $2.2M | -$2.8M | |
Cash From Operations | -$8.6M | -$19.7M | -$25.6M | -$35M | -$16.9M | |
Capital Expenditures | -- | -- | $3M | $15.1M | $6.3M | |
Cash Acquisitions | -- | -- | -- | -- | -$16K | |
Cash From Investing | -$7.1M | -$10.5M | -$3M | $19.1M | -$64.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $1.8M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$5K | -$3K | -$9K | -- | -- | |
Other Financing Activities | -$332K | -- | -$777K | -$2.2M | -$2.3M | |
Cash From Financing | -$76K | $53M | -$457K | $5.4M | -$1.5M | |
Beginning Cash (CF) | $29.2M | $385.4M | $323M | $235.1M | $274.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -$541K | -$228K | |
Additions / Reductions | -$15.8M | $22.9M | -$29.1M | -$10.5M | -$82.8M | |
Ending Cash (CF) | $13.4M | $408.3M | $293.9M | $224.1M | $191.7M | |
Levered Free Cash Flow | -$15.8M | -$30.1M | -$28.6M | -$50.1M | -$23.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$67M | -$167.9M | -$187M | -$199.6M | |
Depreciation & Amoritzation | -- | $1.8M | $11.1M | $55.4M | $28.4M | |
Stock-Based Compensation | $1.6M | $14.4M | $54.3M | $53.1M | $58.1M | |
Change in Accounts Receivable | -- | -- | -$21K | -$14K | -$2.5M | |
Change in Inventories | -- | -- | -$815K | $6.9M | -$4M | |
Cash From Operations | -- | -$62.4M | -$88.7M | -$114.1M | -$90.5M | |
Capital Expenditures | -- | -- | $28.8M | $73.9M | $67.4M | |
Cash Acquisitions | -- | -- | -- | -- | -$16K | |
Cash From Investing | -- | -$46.9M | -$28.8M | -$120.8M | -$84.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $174.3M | $2.8M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$25K | -$16K | -$17K | -- | |
Other Financing Activities | -- | -- | -- | -$28.5M | -$7.1M | |
Cash From Financing | -- | $504.2M | $3M | $165.5M | $143.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $394.9M | -$114.4M | -$69.4M | -$31.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$109.3M | -$117.5M | -$187.9M | -$157.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$16.2M | $42.7M | -$73.6M | -$46.5M | -$23.5M | |
Depreciation & Amoritzation | $141K | $448K | $3.6M | $25M | $8.4M | |
Stock-Based Compensation | $1.6M | $5.2M | $29.2M | $12.8M | $12M | |
Change in Accounts Receivable | -- | -- | $149K | $505K | $430K | |
Change in Inventories | -- | -- | -$181K | $2.2M | -$2.8M | |
Cash From Operations | -$8.6M | -$19.7M | -$25.6M | -$35M | -$16.9M | |
Capital Expenditures | -- | -- | $3M | $15.1M | $6.3M | |
Cash Acquisitions | -- | -- | -- | -- | -$16K | |
Cash From Investing | -$7.1M | -$10.5M | -$3M | $19.1M | -$64.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $1.8M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$5K | -$3K | -$9K | -- | -- | |
Other Financing Activities | -$332K | -- | -$777K | -$2.2M | -$2.3M | |
Cash From Financing | -$76K | $53M | -$457K | $5.4M | -$1.5M | |
Beginning Cash (CF) | $29.2M | $385.4M | $323M | $235.1M | $274.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -$541K | -$228K | |
Additions / Reductions | -$15.8M | $22.9M | -$29.1M | -$10.5M | -$82.8M | |
Ending Cash (CF) | $13.4M | $408.3M | $293.9M | $224.1M | $191.7M | |
Levered Free Cash Flow | -$15.8M | -$30.1M | -$28.6M | -$50.1M | -$23.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.